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Abstract 
This review presents the last advances related to analytical and bioanalytical applications of 
electrochemiluminescence (ECL) achieved by exploiting the special optical or 
electrochemical properties of quantum dots and nanoelectrodes, respectively. After a brief 
introduction which covers the basic concepts of ECL detection, the review presents relevant 
examples dealing with in the use of quantum dots and arrays of nanoelectrodes to improve 
the analytical and bioanalytical capabilities of ECL. Finally, prospects and limits derived 
from the application of the above advanced nanomaterials to stimulate ECL emission are 
discussed.  
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Introduction 
Electrochemiluminescence (ECL) or electrogenerated chemiluminescence is an analytical 
technique in which electrochemically generated intermediates undergo electron-transfer 
reactions to form electronically excited states that emit light[1], [2], [3], [4]. The first detailed 
investigations about ECL were reported by Hercules[5], and Bard[6] in the early 1960’s, even 
though seminal studies regarding light emission under electrolysis conditions were reported 
earlier by Harvey in the 1920’s[7]. As a form of luminescence (e.g. emission of light without 
heat), and in contrast to chemiluminescence (CL) where light emission is the result of a 
chemical reactions between suitable species, ECL has the peculiarity that light emission 
occurs when a suitable potential (oxidation or reduction) is applied at the electrode[3]. As 
such, ECL has several advantages over CL, in particular, the electrochemical reaction allows 
the time and position of the light-emitting reaction to be carefully controlled; control over the 
time means the light emission can be delayed until specific events such as immune or 
enzyme-catalysed reactions have taken place; control over position can be used to confine the 
light emission into a precisely located region with respect to the detector. These advantages 
lead to enhanced sensitivity by increasing the ratio of signal to noise. ECL occurs by means 
of two distinct processes: (i) ion annihilation and (ii) coreactant ECL. Ion annihilation 
involved the formation of excited states as a result of exergonic electron-transfer between 
electrochemically generated species (typically radical ions) at the surface of electrodes. Let 
us consider a luminophore (emitter) species, R, which is oxidised and reduced at the 
electrode. The ion annihilation ECL occurs through the following steps: 
𝑅 −  𝑒−  →  𝑅+∙ (oxidation)      (1) 
𝑅 +  𝑒−  →  𝑅−∙(reduction)      (2) 
𝑅+∙ + 𝑅−∙  → 𝑅 +  𝑅∗ (excited state formation)   (3) 
𝑅∗  → 𝑅 + ℎ𝜐 (light emission)     (4) 
Annihilation occurs in Eq. 3 with the formation of the excited species, R*. Annihilation 
reactions can also occur with different species, i.e. when the radical cation and anion derive 
from different molecules. For ECL co-reactant, let us consider R and C as the emitter and 
coreactant species, respectively. Typically, coreactant ECL is generated by applying an 
anodic or cathodic potential in a solution containing the luminophore and the coreactant. 
Therefore, depending on the polarity of the applied potential, both luminophore and 
coreactant species can be oxidised or reduced at the electrode to form radical ions, and 
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intermediates species followed by decomposition of these species and formation of excited 
states that emit light. Because highly reducing intermediate species are generated after 
electrochemical oxidation of coreactant or highly oxidising intermediates are produced after 
electrochemical reduction, the corresponding ECL reactions are often defined as “oxidative-
reduction” for the former and “reductive-oxidation” ECL for the latter, respectively.  Use of 
coreactant is useful in chemical analysis when one of the R•+ or R•- is not stable enough for 
ECL reaction, or in the case the solvent being used has a narrow potential window so that R•+ 
or R•- cannot be formed. When the annihilation reaction between oxidized and reduced 
species is not efficient, the use of a coreactant may produce more intense ECL. To mention 
also an additional advantage, i.e. the quenching effect due to molecular oxygen, which is 
significant in ion annihilation ECL, may be eliminated during “oxidative-reduction”-type 
ECL, thus the experiment can be conducted in air. The mechanism for coreactant ECL can be 
generalised as follows. Case (a) oxidative-reduction co-reactant ECL: 
𝑅 − 𝑒−  →  𝑅+∙      (5) 
𝐶 − 𝑒−  →  𝐶+∙      (6) 
𝑅+∙ + 𝐶 → 𝑅 +  𝐶+∙      (7) 
𝐶+∙ →  𝐶𝑟𝑒𝑑
⋕        (8) 
𝐶𝑟𝑒𝑑
⋕ + 𝑅 →  𝑅∙− + 𝑃      (9) 
𝑅∙− +  𝑅+∙  → 𝑅 +  𝑅∗ or 𝑅+∙ + 𝐶𝑟𝑒𝑑
⋕  → 𝑅∗ + 𝑃  (10) 
𝑅∗  → 𝑅 + ℎ𝜐       (11) 
Case (b) reductive-oxidation co-reactant ECL: 
𝑅 + 𝑒−  →  𝑅−∙      (12) 
𝐶 + 𝑒−  →  𝐶−∙      (13) 
𝑅−∙ + 𝐶 → 𝑅 +  𝐶−∙      (14) 
𝐶−∙ →  𝐶𝑜𝑥
⋕        (15) 
𝐶𝑜𝑥
⋕ + 𝑅 →  𝑅+∙ + 𝑃      (16) 
𝑅∙− +  𝑅+∙  → 𝑅 +  𝑅∗ or 𝑅−∙ + 𝐶𝑜𝑥
⋕  → 𝑅∗ + 𝑃  (17) 
𝑅∗  → 𝑅 + ℎ𝜐       (18) 
where (5), (6), (12), and (13) represent the redox reactions at the electrode, (7), (8), (9), (14), 
(15), and (16) are homogenous chemical reactions, (10), and (17) the excited state formation 
species, (11), and (18) the light emission, with R representing the emitter, C the co-reactant, 
 4 
 
𝐶𝑟𝑒𝑑
⋕  and 𝐶𝑜𝑥
⋕  are the coreactant intermediates for the reducing and oxidising agents, 
respectively, and P the products associated with 𝐶⋕ reactions. The most common 
luminophore used in coreactant ECL is Ru(bpy)3
2+, while tripropylamine (TPrA), oxalate, 
perdisulfate ions and hydrogen peroxide are the most popular coreactant species[3].  
Many recent devolopments in the study and applications of ECL are related to the new 
prospects  opened by the use of novel nanomaterials and electrodes of nanometric size[8], [9], 
[10], [11], [12]. . The downsizing of the components of the ECL generation/detection system 
allows indeed to exploit some special characteristics observed in materials with critical 
dimension in the few nanometers range. Among the large variety of nanomaterials today 
available, we choose to focus our review on ECL phenomena which exploit the special 
properties of inorganic semiconductor quantum dots and of arrays nanotube/nanodisk 
electrodes, where the control of the size and spatial distribution of the nanocomponents plays 
a well defined role, bringing to increase in ECL emission because of quantum or molecular 
diffusion effects. For reasons of space, the readers interested on recent advances in ECL 
based on different nanomaterials, such as graphene and carbon quantum dots, can refer to 
other specific reviews[13], [14], [15].  Note also that this review focuses on, but is not limited to, 
papers published in the last five years. 
 
ECL of quantum dots 
Semiconducting nanocrystals or quantum dots (QDs) are a class of nanomaterials with unique 
optoelectronic properties that have found a variety of applications, from energy conversion 
systems to electronics and diagnostics[16]. The physical properties of QDs are essentially 
dictated by quantum confinement effects and are considerable different from their analogous 
as bulk materials. To summarise this concept using the band theory, when photons are used to 
excite QDs with energy equal or greater than their band gap, then the resulting effect is the 
excitation of electrons from the valence to the conduction band with concomitant formation 
of a hole in the valence band. The formation of such electron-hole (e-h) pair (“exciton”) is 
bound by electrostatic attraction with the opposite charges and the extension of the exciton 
wave function over the crystal lattice is measured by the Bohr radius[11]. In simpler words, the 
Bohr radius is a measure of the average distance between the holes and the photo-generated 
electrons. A typical example is the case of CdSe QDs, where the Bohr radius is about 6 nm. 
When CdSe QDs have size smaller than the Bohr radius, then the optical and electrical 
properties become dependent on its physical dimensions, owing to quantum confinement 
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effect. When this situation occurs, the band structure of QDs changes into discrete levels and 
the difference in the energy levels between HOMO and LUMO widens as the size particle 
decreases. However, a description based on the molecular orbits rather than on the band 
theories is quite often more appropriate to describe QDs as a system lying between bulk 
materials and molecular species. The process of charge transfer within QDs can be 
summarised as in Figure 1.[17]  The energy required to produce a non-interacting e-h pair is 
defined as a quasi-particle gap, which in fact corresponds to the electrochemical band gap, i.e 
the difference between the first oxidation and first reduction of QDs. The electrochemical 
band gap, ΔEel can be determined voltammetrically (Figure 1c), instead the optical band gap, 
ΔEopt (Figure 1d) can be quantified using spectroscopic data. ΔEel and ΔEopt are correlated by 
the expression: 
 
ΔEopt = ΔEel – Je,h        (19) 
 
Where Je,h is the total Coulombic energy of the e-h pair. Eq. 19 implies that the 
electrochemical band gap is larger than the optical energy gap. Therefore, voltammetric 
methods are very useful to estimate HOMO-LUMO levels in electroactive species, as well as 
to determine parameters such as electron transfer kinetics, diffusion coefficients and kinetic 
constants. More importantly, while with spectroscopic methods it is possible to probe 
processes occurring inside QDs, instead with voltammetric methods it is possible to probe the 
QDs surface states that are inherently defective due to the presence of entangled bonds and 
unsaturated valences.  
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Figure 1. Schematic of mechanism of charge transfer in semiconducting QDs: (a) electron-transfer from a 
conductive electrode to neutral particle; (b) hole injection from electrode to QDs (“electron-extraction”); (c) 
simultaneous injection of electron and hole in two non-interacting QDs; (d) generation of electron-hole (“e-h”) 
pair within the same QDs. Reprinted from Ref. [16] with permission of the Royal Society of Chemistry. 
 
Since the initial discovery of QDs in 1983 from Brus et al. [18],[19], and breakthrough 
applications in bioanalysis from Alivisatos[20] and Nie[21], in the last decade the number of 
works related to QDs in chemical analysis has dramatically increased. The first seminal 
description of electrochemiluminescence from QDs was reported by Bard in 2002 and 
involved the ECL generation from germanium[22] and silicon[23] nanocrystals in DMF. Soon 
after, ECL works of functionalised CdSe[24], core-shell CdSe/ZnSe[25], and CdTe QDs[26] in 
organic solvents followed. However, a real breakthrough of ECL of QDs in bioanalysis is 
represented by the work of Liu et al. in which for the first time the synthesis of water soluble 
mercaptopropionic-capped CdTe and anodic ECL detection of cathecol derivatives was 
reported[27]. In QDs, the ECL processes involve the formation of high-energy electron 
transfer reactions with formation of excited species. From the formation of excited species, 
the emission of light occurs through two distinct mechanisms, (i) annihilation and (ii) 
coreactant ones. The annihilation pathway involved with QDs can be summarised as follows 
[10], [28]: 
𝑄𝐷𝑠  +  𝑒
− → 𝑄𝐷𝑠
−∙
      (20) 
𝑄𝐷𝑠  −  𝑒
− → 𝑄𝐷𝑠
+∙
      (21) 
𝑄𝐷𝑠
+∙ +  𝑄𝐷𝑠
−∙ →  𝑄𝐷𝑠 + 𝑄𝐷𝑠
∗    (22) 
𝑄𝐷𝑠
∗  →  𝑄𝐷𝑠 + ℎ𝜐      (23) 
The radical ions formed in Eq. 20 and 21 during the reduction and oxidation scans, 
respectively, are unstable and characterised by short life time. The reactions between the 
radical anions and cations leads to the formation of the excited species QDs* which emits 
light at the characteristic wavelength of the as-prepared QDs. Note that the annihilation 
pathway requires only the presence of the luminophore species (QDs), solvent and supporting 
electrolyte to generate light, however a major drawback is represented by the fact that in 
bioanalysis, the potential window of aqueous solution is often not wide enough to allow the 
formation of radical ions (cations and anions). In this case, organic solvents such as 
acetonitrile and N,N-dimethylformamide must be utilised, which is not practical for 
bioanalytical applications[4], [29]. Also, annihilation requires that the life-time of the 
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electrogenerated species must be long enough to react and to produce the excited species: 
obviously, this is an intrinsic limitation, especially if the electrogenerated species is prone to 
react with the solvent. This implies that in real samples the coreactant pathway is largely the 
predominant route utilised in ECL. In the coreactant pathway, co-reactant species are 
oxidised and reduced at the electrode surface, with the formation of radical cations or radical 
anions. These radical ions react with the oxidised or reduced formed of QDs leading to the 
formation of excited quantum dots, QDs*. The main difference with the annihilation pathway 
in which oxidised and reduced ECL species must be generated at the same time, is that 
coreactant ECL occurs by sweeping the electrode potential in one direction (anodic or 
cathodic) with the luminophore (QDs) reacting with radical ions from the coreactant species. 
The coreactant pathway is usually classified as (i) oxidative-reduction or (ii) reductive-
oxidation as previously mentioned, and accordingly to the intermediate species generated 
during the anodic or cathodic potential sweep. Typical ECL coreactants belonging to the 
oxidative-reduction include TPrA, dibutylaminoethanol (DBAE), oxalate (C2O4
2-) and sulfite 
(SO3
2-) species, while molecular oxygen (O2), hydrogen peroxide (H2O2) and perdisulfate 
(S2O8
2-)[10], [30] are the most common coreactants belonging to the reductive-oxidation 
pathway. It is useful to recall the mechanism of reactions of QDs with TPrA and H2O2, which 
are the most common coreactant utilised in bioanalysis. For the oxidative-reduction pathway 
the mechanism of ECL generation is as follows[31], [32]: 
𝑇𝑃𝑟𝐴 − 𝑒−  →  𝑇𝑃𝑟𝐴+∙            (24) 
𝑇𝑃𝑟𝐴+∙ →  𝑇𝑃𝑟𝐴∙ +  𝐻+     (25) 
𝑄𝐷𝑠 −  𝑒
− → 𝑄𝐷𝑠
+∙      (26) 
𝑇𝑃𝑟𝐴∙ +  𝑄𝐷𝑠
+∙ → 𝑇𝑃𝑟𝐴 𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡𝑠 +  𝑄𝐷𝑠
∗   (27) 
𝑄𝐷𝑠
∗  →  𝑄𝐷𝑠 + ℎ𝜐      (28) 
 
In anodic ECL, the electrode first injects holes into the valence band of QDs with 
concomitant injection of electrons provided by the oxidation of the coreactant. Then, 
recombination of holes and electrons leads to anodic ECL. The process is summarised in 
Figure 2. 
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Figure 2. Anodic (A) and cathodic (B) ECL of QDs deposited on electrode surfaces in the presence of co-
reactant speciess. Reprinted from Ref. [11] with permission of the American Chemical Society. 
 
For the reductive-oxidation pathway, the ECL generation occurs as follows[33]: 
𝐻2𝑂2 + 𝑒
− →  𝑂𝐻− +  𝑂𝐻∙    (29) 
𝑄𝐷𝑠 +  𝑒
− → 𝑄𝐷𝑠
−∙     (30) 
𝑄𝐷𝑠
−∙ +  𝑂𝐻∙  →  𝑄𝐷𝑠
∗ +  𝑂𝐻−   (31) 
𝑄𝐷𝑠
∗  →  𝑄𝐷𝑠 + ℎ𝜐     (32) 
In this case, the role of the electrode and coreactant, and with them the role of holes and 
electrons are exchanged. Key advantages of the coreactant pathway is that the ECL 
generation is facilitated in aqueous solutions, opening up various and disparate possibilities 
for developing ECL-based essays for medical diagnostics[4]. ECL applications of QDs in 
bioanalysis coupled with the possibility of engineering their size, shape and composition at 
the nanoscale are opening up unprecedented opportunities. However, works related to ECL of 
QDs can be divided into four main streams: (i) synthesis of water compatible QDs, (ii) 
assembly of QDs on electrode surfaces, (iii) functionalisation and bioconjugation of QDs 
with biomolecules and chromophores, and (iv) integration of QDs-bioconjugated molecules 
into specific bioassays[11], [23],[34], [29] [35], [36], [37]. Herein, we focus on some of the most recent 
applications of QDs in bioanalysis. 
Liu et al. developed a novel dual-stabiliser-capped synthetic strategy for preparing CdSe QDs 
for ECL detection of dopamine[38]. This synthetic strategy involves the immobilisation of 
marcaptopropionic-protected CdSe QDs on p-aminobenzoic acid modified glassy carbon 
electrodes and ethylenediamine as a link molecule. This procedure, summarised in Figure 3, 
allowed the synthesis of QDs with strong monochromatic ECL emission at 546 nm with 
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concomitant passivation of the QDs surface. In this way, non-radiative surface states and 
surface traps are removed, leading to high monochromaticity and highly efficient e-h 
injection. 
 
Fig. 3. Schematic of ECL configuration strategy. Reprinted from Ref. [38] with permission of the American 
Chemical Society. 
 
The as-prepared ECL sensor allowed detection of dopamine in the linear range 10 nM – 3μM 
with a limit of detection of 3 nM without any signal amplification technique, by means of 
quenching of the ECL signal in the presence of S2O8
2- as coreactant.  While H2O2 is the most 
common coreactant for ECL in the cathodic region, only recently a detailed study from 
Russell et al. using a variety of coreactants has shown that S2O8
2- is the most efficient among 
the coreactants[39]. The last five years have seen an explosion of ECL-based reports with a 
combination of a variety of nanomaterials, in particular gold nanoparticles (Au NPs)[36], silica 
nanoparticles (Si NPs)[40] and carbon nanomaterials (graphene, carbon QDs)[41], [42]. Such a 
combination of nanomaterials allows in principle the detection of the most disparate analytes 
in medical diagnostics. An interesting approach has been developed by Guo et al. for the 
simultaneous determination of two tumour markers, namely, alpha-fetoprotein (AFP), and 
carcinoembryonic antigen (CEA), using multicolour CdSe/ZnS QDs as labels and graphene 
as conducting bridge[43]. Two different sized CdSe/ZnS QDs were utilised to label secondary 
anti-AFP and anti-CEA antibodies. Such an approach allowed the production of two 
distinguished ECL signals at 525 nm and 625 nm without interference, with graphene acting 
as conducting bridge to promote electron transfer between QDs and the electrodes. A 30-fold 
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magnification of the ECL signal was evidenced in the presence of S2O8
2- as co-reactant.  A 
summary of the procedure utilised for the fabrication of the immunosensor is reported in 
Figure 4. This configuration enabled the simultaneous detection of AFP and CEA with a 
linear range of 0.001 – 0.1 pg/mL and detection limits for both analytes down to 0.4 fg/mL 
with no obvious cross-reactivity.  
 
 
Figure 4. Schematic representation of (A) preparation of colloidal anti-AFP2/QDs525 and anti-CEA2/QDs625 
conjugates; (B) procedure for the fabrication of immunosensor. Reprinted from Ref. [43] with permission of 
Elsevier Ltd. 
 
A similar approach, but using core-shell Fe3O4- magnetic Au nanoparticles, was used to 
detect carbohydrate antigen (a cancer marker associated to ovarian cancer) at a concentration 
of 1.2 mU/mL as demonstrated by Liu et al.[44] Similar, but complementary strategies were 
utilised by Zhou et al. [45] with the development of a sandwich-type ECL immunosensor for 
detection of AFP, down to 0.2 pg/mL, using a combination of magnetic Fe3O4 nanoparticles 
with CdS QDs and Au NPs. Another interesting example of combination of nanomaterials is 
represented by the work of Li et al. [46]. In their work, 3D graphene was deposited on glassy 
carbon electrodes, followed by incorporation into the 3D graphene structure of CdSeTe QDs 
labelled with Ru(bpy)3
2+-doped Si NPs. The as-proposed ECL sensor allowed detection of 
ultra-trace concentration of folic acid up to 3.5 aM with a 2-3 order of magnitude 
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improvement in the limits of detection compared to chromatographic, and other (non-ECL 
based) electrochemical methods. Similar procedures, using CdTe QDs, were adopted by 
Wang et al. to detect ochratoxin A down to 3 fg/mL in real samples[47] and by Zhang et al. to 
detect prostate specific antigen (PSA) with detection limits of ca. 3 pg/mL[48]. 
DNA detection is a rapidly expanding area in chemical analysis and achieving low detection 
limits is of paramount importance. ECL-based detection is an exciting strategy in order to 
achieve low detection limits, highly selectivity and repeatability. Recently, Zhang and 
coworkers developed a novel ratiometric approach for DNA biosensing[49]. The ratiometric 
approach is based on the use of dual excitation or dual emission dyes and can be applied to 
chemical species having at least two peaks in their excitation and/or emission spectrum. This 
method is extremely useful when the ratio of the fluorescence intensities at these wavelengths 
correlates with the concentration of the analyte, since it can reduce the influence from 
environmental changes such as scattering, path length, photobleaching etc. CdS QDs were 
coated on glassy carbon electeodes and ECL was performed in the presence of luminol as 
chromophore and H2O2 as coreactant. The ECL signal from CdS QDs can be effectively 
quenched by contacting them with Pt NPs through a biological binding event (in this specific 
case using mp53 oncogene, as a model DNA molecule), meanwhile the ECL from luminol 
can be enhanced by the presence of Pt NPs. Thus, the quenching of ECL from CdS QDs and 
the enhancement of ECL from luminol could indicate the same biological binding event. A 
molecular beacon (MB) containing a 20-base loop, which is complementary with the mp53 
oncogene, was immobilized on CdS QDs followed the procedure highlighted in Figure 5. Pt 
NPs were then attached on CdS QDs surface by DNA hybridization between the MB and 
mp53 oncogene labelled on Pt NPs. By measuring the ratio of ECL intensities at two 
excitation potentials, this approach led to the detection of the concentration of target DNA in 
a wide range, from 5.0 fM to 1.0 pM. The proposed approach is generally applicable and 
adaptable to other biological binding events. 
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Figure. 5. Schematic of ECL ratiometric system. Reprinted from ref.[49] with permission of  the American 
Chemical Society. 
 
Recent advances on ECL detection with semiconducting quantum dots include the possibility 
of using spectral resolved ECL to detect single molecule events. This is achieved by lowering 
the background noise using charged-couple devices (CCDs)-monochromator and by proper 
functionalisation of QDs. In this respect, Zhang et al. reported the synthesis of dual-
stabilisers CdSe QDs as a ECL label and CEA antigen as target molecule. This configuration 
allowed detection of CEA up to 0.1 fg/mL using only 20 μl of serum sample[50]. Furthermore, 
a similar approach was used by the same authors to detect AFP using ternary CdZsSe QDs[51] 
with limit of detection of 0.01 pg/mL and PSA up to 10 fg/mL using ternary CdZnSe QDs 
and dual-stabilisers CdZe QDs[52], respectively. 
The versatility of ECL is represented not only by the combination of several classes of 
nanomaterials, but also by the possibility of integration with other analytical methods. A very 
exciting combination which is now receiving particular attention has led to the development 
of a novel analytical technique called electrochemiluminescence-energy transfer (ECL-
ET)[53]. Luminescence resonance energy transfer (LRET) is an analytical technique for the 
detection of traces of biomolecules through non-radiative processes. In LRET a luminescent 
donor species transfers energy to a near acceptor species (luminescent or non-luminescent) 
via non-radiative dipole-dipole interactions[54]. The rate of energy transfer is highly 
dependent on the extent of spectral overlap and the distance between the donor and acceptor 
species. According to the different types of luminescence from the donor species, three major 
types of LRET have been defined, (i) fluorescence (or Förster) resonance energy transfer 
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(FRET)[55], [56], chemiluminescence resonance energy transfer (CRET)[57], [58], [59], and 
bioluminescence resonance energy transfer (BRET)[60], [61]. To achieve enhanced ECL-ET 
efficiency, optimum energy overlapping of donor/acceptor species is of crucial importance. 
In this respect, materials with tunable spectroscopic properties are particularly appealing as 
potential donor and acceptor species. Notably, the tunable emission wavelength and broad 
absorption spectra of QDs render them an ideal class of material for ECL-ET. QDs with near-
infrared (NIR) emission (650–900 nm) are particularly attractive, as biological auto-
fluorescence and tissue absorption are both at their minima in this wavelength range. So far 
many kinds of NIR-emitting QDs have been reported, such as CdSeTe, InAs, PbSe, CdP and 
CuInS, etc,[62], [63] and among them CdSeTe QDs have been of tremendous interest since their 
first report in 2003[64]. In comparison with other NIR-emitting QDs, CdSeTe QDs exhibit a 
very strong non-linear effect between composition and the absorption/emission energies, 
conferring them special optical and electronic properties not available from parent species 
such as CdSe and CdTe QDs. Therefore, the emission wavelength of CdTeSe QDs can 
readily reach NIR region by tuning the Te/Se molar ratio. This is a great advantage 
considering that CdSe QDs typically cover the region 480–620 nm in emission, while CdTe 
QDs (specifically 7 nm in size) can reach not more than 720 nm in emission[65]. However, the 
toxicity of Cd2+ released from CdSe or CdTe QDs represents a limitation for bioanalytical 
applications[66], [67], [68]. To overcome this issue, a solution is represented by using core-shell 
QDs, e.g. coating the Cd core with a suitable shell such as ZnS, even though two stringent 
conditions must be fulfilled: (i) the shell material should possess a much wider band gap than 
the core to suppress the exciton leakage into the shell; (ii) the core and shell materials should 
have similar lattice parameters so that the shell-growth occurs in an epitaxial manner, without 
the formation of structural defects which would hamper the quantum yield[69]. Typically, 
CdSeTe QDs are passivated with non-toxic ZnS shell to obtain core-shell CdSeTe/ZnS. 
However, for both CdSe and CdTe, the large lattice mismatches (>10%) relative to ZnS 
hinder the formation of high-quality core-shell QDs. This implies the development of novel 
synthetic procedure in aqueous media to fabricate NIR-emitting core-shell CdTeSe QDs with 
the desired optical properties and low biotoxicity. Examples of core-shell QDs are 
represented in Figure 6. 
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Figure 6. (a) Interrelationship between band gap energy, lattice constant, and lattice mismatch of bulk cubic 
CdTe, CdSe, CdS, and ZnS.  (b) Synthetic procedures for the preparation of CdSeTe/CdS/ZnS QDs. (c) Photo 
images of the prepared CdSeTe/CdS QDs (samples 1–9) and CdSeTe/CdS/ZnS QDs (sample 10, relative to 
sample 7) taken under visible (upper) and UV light (lower), respectively. Reprinted from ref. [53] with 
permission of the Nature Publishing Group. 
 
ECL-ET are widely utilised in medical diagnostics to develop novel sensing tools. A near-
infrared (NIR)-ECL-ET aptasensor for detection of thrombin was developed by Wang et 
al.[70]. In this work core-shell CdTe/CdS QDs and Au nanorods were utilised for ECL-ET 
detection of thrombin in the presence of S2O8
2- as coreactant. With QDs acting as donor and 
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Au nanorods as acceptor species, respectively, in the absence of thrombin the ECL signal was 
effectively quenched as a direct effect of ECL-ET between QDs and Au nanorods. In 
contrast, in the presence of thrombin, the NIR-ECL-ET become “turned-on” due to the 
effective replacement of Au nanorods with thrombin ascribed to the specific aptamer-protein 
affinity interaction. This allowed a remarkable increment of the ECL signal and the 
possibility to detect thrombin in serum in the concentration range 100 aM-10 fM with a 
detection limit of 3 fM. Later on, using CdSe/ZnS QDs and luminol but in the absence of co-
reactant, Dong and coworkers were able to improve the detection limit of thrombin down to 
1.4 fM[71]. A similar ECL-ET concept using CdS but with Au NPs was used for studies of 
DNA binding with proteins [72]. Another interesting approach that led to a significant 
enhancement in the ECL-ET signal involved the formation of CdS:Eu nanocrystals. In this 
work Zhou et al. were able to detect target DNA in the range 10 aM-10 pM   in the presence 
of S2O8
2- as co-reactant[73]. In this case, the addition of Eu3+ ions has a beneficial effect by 
creating new surface states that enhance the ECL signal. Interestingly, the ECL signal has 
two spectral bands, the first one at 450-550 nm from CdS and the second one at 600-700 nm 
caused by the energy transfer between CdS and Eu3+ ions. Further recent and significant 
development in ECL-ET is the combination of CdS:Eu nanocrystals with biocompatible 
Ru(bpy)3
2+-doped silica nanoparticles (RuSi) for detection of prostate specific antigen 
(PSA)[74]. This combination enhanced the ECL-ET signal up to ca. 5-fold due to efficient 
ECL-ET and high Ru(bpy)3
2+ quantum yield leading to reaching detection limit for PSA up to 
1 fg/mL[74]. In a similar procedure Wu et al. utilised graphene oxide- Au NPs previously 
functionalised with RuSi NPs and chitosan as the donor composite, with Au/Ag2S NPs as the 
acceptor[75]. This work led to ECL-ET detection of target DNA in the range from 10 aM-10 
pM in the presence of TPrA as co-reactant.  The versatility of ECL is clearly evident when is 
combined with other analytical techniques. One of the most significant combination is 
represented by the surface-enhanced electrochemiluminescence (SEECL)[76], despite the first 
seminal work on surface plasmon coupled with ECL was reported by Lakowicz in 2004[77]. In 
this work, it has been shown that electrochemically-generated excited states of Ru(bpy)3
2+ 
can excite the surface plasmon of Au thin films. This concept demonstrated that surface 
plasmon can be excited by excited states of luminophores. Since then, studies of the 
interaction between the ECL of semiconductor QDs and the localised surface plasmon 
resonance of noble metal nanostructures has been investigated[78], [79]. The mechanism of 
ECL, summarised in Figure 7 occurs in two steps.  
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Figure 7. Schematic diagram of SEECL. Reprinted from Ref. [76]  with permission of the Nature Publishing 
Group. 
 
The first step is the electrochemical generation of excited states of the luminophore, 
Ru(bpy)3
2+* with TPrA, the second step involves the generation of the plasmon resonance at 
the surface of Au NPs in a similar way as previously demonstrated by Lakowicz in the case 
of a thin Au film [77].  The enhancement in the ECL signal can be explained with similarity 
with fluorescence. In this case the ECL efficiency can be quantified by the gain in the relative 
molecular detection efficiency, MDE. At the position 𝑟0, MDE can be expressed by the 
expression: 
𝑀𝐷𝐸(𝑟0) = Γ𝑒𝑥𝑐(𝑟0) 𝑥 𝑄 𝑥 𝑀𝐶𝐸(𝑟0)   (33) 
Where Γ𝑒𝑥𝑐(𝑟0) is the excitation rate, 𝑄 is the ECL quantum yield, and 𝑀𝐶𝐸(𝑟0) represents 
the molecular collection efficiency function at point 𝑟0.
[76]. This mechanism is proposed on 
the ground that the luminophore is excited by a propagating or an evanescent electromagnetic 
field. Because the localised surface plasmon resonance induced magnetic field belongs to 
electromagnetic field, then it is reasonable to assume that the electromagnetic field can excite 
the luminophore from the ground to the excited state leading to an increase of the excitation 
rate Γ𝑒𝑥𝑐(𝑟0). Also, the electromagnetic field increases the emission factor (𝑄 𝑥 𝑀𝐶𝐸(𝑟0)) of 
Ru(bpy)3
2+*. Key for the ECL enhancement is the control of the inter-distance between 
 17 
 
luminophore and Au NPs. Then, the same authors demonstrated the suitability of SEECL for 
detection of CEA in human serum[80]. As one of the most important cancer biomarker, CEA 
detection has received significant attention. Ru(bpy)3
2+-doped SiO2 NPs were used as ECL 
luminophores with AuNPs utilised as LSPR source to enhance the ECL signal. Two different 
kinds of aptamers specific to CEA were modified on the surface of SiO2 NPs and Au NPs. 
This configuration and TPrA as co-reactant allowed the detection of CEA with detection 
limits of ca. 1.5 ng/mL in human serum and demonstrated the suitability of the surface 
plasmon resonance to amplify the ECL signal (see Figure 8). 
 
Figure 8. (A) Concentration-dependent ECL of the biosensor ad different CEA concentrations (from 5 (top), to 
5× 10−6 ng/mL (bottom), respectively. (B) The calibration curve for quantification of CEA. Experimental 
conditions: 0.1M pH 7.4 PBS and 1 mM TPrA. The scan rate is 100 mV/s for all measurements. Reprinted from 
ref. [80]  with permission of the American Chemical Society. 
 
Previously, the same authors utilised a slightly modified experimental set-up to detect ultra-
trace concentrations of Hg2+[81]. Specifically, Au nanorods and T-rich DNA were self-
assembled on the surface of gold electrode. In the presence of Hg2+, the conformation of ss-
DNA probes changed towards a hairpin-like structure with formation of a T-Hg2+-T structure 
(see Figure 9). The insertion of a luminophore such as Ru(bpy)3
2+ into the grooves of the 
hairpin structured DNA probes generated ECL emission, further enhanced by the localised 
surface plasmon resonance of Au nanorods. The ECL intensity of the sensor increased 
linearly with the concentration of Hg2+, with a detection limit of 10 fM.  
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Figure 9. schematic of SEECL detection of Hg2+. Reprinted from Ref. [81]  with permission of Elsevier Ltd. 
 
Later on, the same concept has been utilised by the same authors to detect PSA in whole 
blood without sample treatment achieving detection limits for PSA of 2 pg/mL[82].  
 
ECL with arrays of nanowire, nanotube and nanodisk electrodes  
 
ECL at the nanoscale presents attractive features[74], however, particularly for the case of 
working with electrodes of nanometric dimensions, it represents also a great challenge, 
particularly from the technical view point. One important advantage to use smaller and 
smaller electrodes lies in the fact that one could perform almost punctual ECL measurements 
in extremely localized sites, such as biological sub-cellular organelles, discontinuity points in 
heterogeneous or microporous surfaces, as well as in micro- and nanostructured sensors and 
biosensors. Pushing the dimensional limit of ECL in the hundreds of nanometer range or 
lower presents fascinating prospects also from improving fundamental knowledge on ECL 
mechanism. For instance, it is not known what could be the effect of decreasing the 
dimension of the ECL reaction layer when making it dimensionally comparable with the 
thickness of the electrochemical double layer (that is in the few tens of nanometer 
dimension). The main technical problem to achieve these goals lies in the fact that the 
intensity of ECL emission at an individual electrode of nanometric dimension can be too 
feeble to be detected. For instance, Jiang and coworkers observed that ECL emission from a 
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recessed nanoring electrode (180 nm thick, 30 µm ring diameter, 30 µm recession depth) 
cannot be detected by usual ECL measurement methods[83]. Note that ECL at a ITO 
microdisk electrode of the same diameter (namely, 30 µm) was easily detected. In principle, 
these problems could be overcome by using innovative ECL detection approaches, but at the 
present state of the art, detection of weak ECL emission signals, localized at the nanoscale, is 
still an open challenge. A way to circumvent the problem is to use arrays of nanoelectrodes, 
instead of individual ones, so taking advantage of relevant amplification effects on the overall 
intensity of ECL emission, that are operative when overlapping conditions between the 
reaction layers at neighboring electrodes occur. 
Both from a microfabrication and ECL detection viewpoint, one can distinguish two types of 
arrays of nanoelectrodes exploited for ECL generation: i) arrays of conductive nanowires or 
nanotubes, assembled in nano-arrangements; ii) arrays of nanoelectrodes produced in 
geometrically controlled nanostructures. 
The first group includes macro- and microelectrodes modified by deposition of conductive 
nanomaterials, typically carbon nanotubes (CNTs), deposited by casting, sprying, printing or 
similar approaches.  
For ECL applications, CNTs are attractive since they are characterized by a fast  
electrochemical kinetics for the oxidation of tertiary amines (typical co-reactants in ECL) 
while water oxidation (an undesired side reaction in ECL) presents a high overpotential on 
this class of nanomaterials[84]. CNTs have been deposited on different supporting electrode 
materials, such as Au, ITO or glassy carbon (GC). For instance, Rusling and coworkers 
obtained CNTs arrays arranged in vertically aligned structures named carbon nanotubes 
forests, which were applied at first for electrochemical detection[85], [84], to be further 
developed to prepare an ECL immunosensor for immunoglobulin G (IgG)[86]. In this sensor, 
capture anti-IgG antibodies were bound onto vertically aligned single wall carbon nanotubes 
(SWCNTs) via amide bond formation with the carboxylic groups present on the CNTs wall. 
ECL was generated by binding both a suitable Ru(bpy)3
2+ derivative and IgG on amine 
functionalized silica nanoparticles. The sensor was able to detect IgG down to the pico-molar 
level. 
This ECL approach was further implemented to develop  an ECL immunoarray incorporated 
into a prototype microfluidic device, schematized in Figure 10[87]. It was demonstrated that 
the device is suitable for highly sensitive protein detection and can be used for the accurate 
and sensitive determination of PSA and interleukin-6 (IL-6) in serum.  
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Figure 10. Design of microfluidic ECL array: (1) syringe pump, (2) injector valve, (3) switch valve to guide 
the sample to the desired channel, (4) tubing for inlet, (5) outlet, (6) poly(methylmethacrylate) (PMMA) 
plate, (7) Pt counter wire, (8) Ag/AgCl reference wire (wires are on the underside of PMMA plate), (9) 
polydimethylsiloxane (PDMS) channels, (10) pyrolytic graphite chip (PG) (2.5 × 2.5 cm) (black), with 
hydrophobic polymer (grey) to make microwells. Bottoms of microwells (red rectangles) contain primary 
antibody-decorated SWCNT forests, (11) ECL label containing RuBPY-silica nanoparticles with cognate 
secondary antibodies is injected to bind to the capture protein analytes previously bound to cognate primary 
antibodies. ECL is detected with a CCD camera. Reprinted from Ref.[87] with permission of Springer. 
 
The following evolution of this concept is represented by an automated multiplexed ECL 
immunosensor[88] suitable for the simultaneous detection of four cancer biomarkers, namely 
PSA, prostate specific membrane antigen (PSMA), platelet factor-4 (PF-4) and IL-6.The 
device can detect the four analytes in 36 min, with detection limits in the 10-100 fg/mL 
range. Note that ECL was generated at 0.95 V, using TPrA oxidation to stimulate ECL 
emission, according to the so called revisited route for ECL emission, proposed by Miao, 
Choi and Bard[89] . A CCD camera was used to measure the luminescence emitted from the 
array. 
A sensitive ECL immunosensor for marine toxins was developed by Zamolo et al. [90], by 
exploiting MWCNTs difunctionalized by the procedure summarized in Figure 11.  
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Figure 11. Preparation of Doubly Functionalized MWCNT. Reprinted from Ref.[90] with permission of the 
American Chemical Society. 
 
 
The so introduced maleimido groups are exploited to bind onto the CNT the capture 
antibody, while the amino terminated functionalities are exploited to graft the functionalized 
nanotube on a ITO electrode coated with electropolymerized N-succinimidyl polyacrylate  
(see Figure 12). Finally, the capture Ab binds the analyte, namely palytoxin (PITX) and the 
recognition event is detected using a sec-Ab labeled with a Ru(bpy)3
2+ derivative. By using 
the ECL sensor, PITX was successfully detected in real samples (mussels), with a 
quantification limit of 2.2 µg/kg that is significantly lower value than the one achieved via 
LC-MS/MS.  
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Figure 12. (a) Electrografting of ITO with NSA. (b) Functionalization of MWCNT–mAb1. (c) Addition of 
biotin–PlTX (purple sphere) followed by pAb2-Ru. (d) Addition of the TPRA co-reactant. (e) ECL development. 
Reprinted from Ref.[90] with permission of the American Chemical Society. 
 
Valenti et al. [91] studied an original procedure to produce transparent electrodes for ECL use, 
where CNTs constitute the electrode conductive layer, without the need of using any other 
electrode material. The transparent CNT electrode was fabricated by careful evaporation onto 
a transparent substrate (either glass or polyethylene terephthalate) of a CNT solution in 
tetrahydrofuran, after suitable chemical reduction-reoxidation steps performed under 
controlled atmosphere. The CNT-transparent electrode demonstrated electrocatalytic 
properties superior to classical ITO transparent electrodes, as evaluated from the cyclic 
voltammetric peak-to-peak potential separation values, which, for reversible redox probes, 
matches the 60 mV theoretical value, even at high scan rates. The ECL emission efficiency, 
for the Ru(bpy)3
2+/TPrA systems, was ten times higher than with ITO electrodes. As a proof 
of concept, ECL imaging from Ru(bpy)3
2+ functionalized silica microbeads was proved as a 
model to mimic single cell visualization. 
Nanotubes other than CNTs have been also used for improving ECL emission. Dai and 
coworkers developed a sensitive and stable ECL platform made of titanate nanotubes (TNTs) 
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incorporated in a Nafion layer[92]. The photocatalytic activity of the TNTs was exploited to 
enhance luminol ECL emission using H2O2 as the coreactant or analyte.  In principle, the 
platform can be combined with suitable oxidase enzymes which use oxygen as electron 
acceptor to produce H2O2, catalyzing the oxidation of various biochemical substrates. 
However, the authors did not present any applicative example to confirm experimentally this 
prospect.   
Numerous studies developed in the last years have demonstrated that the efficiency of 
diffusion at electrode/solution interfaces increases dramatically when the critical dimensions 
of the electrode are lowered down to the nanometer range[93], [94], [95] . 
Because of possible co-operation between neighbouring electrodes, these effects are even 
more relevant, and can be more easily detected, when using arrays of nanoelectrodes, for 
reviews see e.g. [96], [97]. In nanoelectrode ensemble (NEE) and in nanoelectrode array (NEA), 
individual nanoelectrodes are randomly or orderly distributed, respectively.  
NEAs fabrication requires the use of bottom-up nanotech approaches, such as electron or ion-
beam lithography or nanoimprinting[98], [99]. NEEs are typically fabricated by bottom-up 
approaches, the most widely used being electrochemical or electroless deposition of a metal 
in the pores of microporous templating membranes, introduced by C.R. Martin and 
coworkers[100], [101].  NEEs/NEAs are characterized by improved electrochemical 
performances because their nanoscopic dimensions reflect in very low capacitive currents, so 
dramatically lowering detection limits[101], [102], [103], [104], [105] . Moreover, arrays have the 
advantage to furnish significantly higher currents than individual nanoelectrodes, without 
requiring sophisticated electronic amplification of current, nor shielding with a Faraday cage. 
The enhanced efficiency of mass transport at nanoelectrodes  has dramatic consequences on 
the role played by the kinetics of the electron transfer[100], [106], [107], [108] or of chemical 
reactions associated with the electron transfer, including those reactions involved in ECL 
emission. Indeed, the increased efficiency of diffusion at nanoelectrodes means that other 
kinetic steps (e.g. heterogeneous electron transfer or chemical reactions) can become the 
bottleneck of the overall electron transfer process. Up to now, the electrochemical behaviour 
of redox processes at NEEs/NEAs have been studied mainly for the case of rather simple 
electron transfer processes, involving the direct reduction/oxidation of reversible or quasi-
reversible redox probes, eventually coupled with very fast (and therefore kinetically un-
influent) chemical reactions[109], [110], [111]. This holds for theoretical studies as well[112], [113]. 
As far as ECL generation at arrays of micro- or nanoelectrodes is concerned, only few papers 
dealt with ECL generation at microband electrodes and microfabricated interdigitated 
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electrode arrays[114], [115], [116]. Recently, bipolar electrochemistry was used to stimulate ECL 
emission from arrays of microband electrodes  or dispersions of conductive  micro-objects 
[117], [118]. 
A bipolar electrode (BPE) is an electronic conductor at the two ends of which two opposite 
electrochemical processes (namely, an oxidation on one side and a reduction  on the other 
side)  occur, without the need  of a direct contact with an external power source;  for recent 
reviews see e.g.[119], [120], [121]. In addition to BPE(s), the functioning of a bipolar 
electrochemical cell requires two auxiliary electrodes, named driving electrodes, which are 
connected to an external power source to induce the polarization of the BPE(s). Bipolar 
electrochemical cells can be designed as open bipolar electrochemical cells (OBPECs) and 
closed bipolar electrochemical cells (CBPECs). 
 
 
 
Figure 13. Graphic representation of an open bipolar electrochemical cell. Reprinted from Ref.[119] with 
permission of Wiley-VCH. 
 
As shown in Figure 13, in OBPEC, the BPE is a conductor dipped in an electrolyte; the 
application of a suitable potential difference between the driving electrodes generates a 
current which flows via ionic or electronic pathways. The electronic path is maximized when 
using a conductive BPE in a resistive solution. If a voltage is applied between the driving 
electrodes, a potential difference (ΔV) is generated between the two poles of the BPE and the 
electrolyte solution is produced because of the polarization of the latter, according to eq.34: 
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∆𝑉 = 𝐸 ∙  𝑙         (34) 
where E is the intensity of the electric field and l is the length of the BPE. 
Therefore, in order to apply bipolar electrochemistry in open configuration to nanosized 
substrates, electric fields in the order of tens of kV/m must be used[122] . 
 
 
Figure 14. Graphic representation of closed bipolar electrochemical cell; A and C are the driving electrodes 
used as anode and cathode, respectively. Reprinted from Ref.[123] with permission of Wiley-VCH. 
 
This limit can be overcome by using CBPEC, where a conductive substrate (the BPE) 
obstructs the cell dividing it into two half-cells each containing a driving electrode (Figure 
14). If the half-cells contain suitable concentrations of electroactive electrolytes, ΔV at the 
BPE does not depend on its dimension, being substantially equal to the potential difference 
between the driving electrodes. Note that in this configuration, all the current flows only 
through the BPE substrate. In CBPECs, the BPE can be an individual conductive object or a 
composite material in which conductive particles are embedded in an insulating matrix. It 
was recently demonstrated that using a CBPEC it is possible to perform bipolar 
electrochemistry even at ensembles of nanowire electrodes of 30-60 nm diameter and few µm 
length, by using low intensity electric fields, in concentrated electrolyte solutions [123]. Since 
the cell is composed of two separated compartments, the two different electrolyte solution 
can operate in distinct experimental conditions such as temperature, or, viscosity.  
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Using the CBPEC approach, Wang and coworkers, developed a multichannel closed bipolar 
array suitable for ECL sensing[124]. It is based on a microporous poly(ethylene terephthalate) 
(PET) membrane where the pores have been filled with gold nanowires (420 nm diameter) 
deposited electrochemically or chemically. The detection principle is schematized in Figure 
15. The ECL readout was detected at the compartment on the left, being coupled with a 
reduction process occurring in the compartment on the right. By this design, it was possible 
to detect a variety of targets which including oxidants, coreactants, quenchers, and 
biomarkers by using the same Ru(bpy)3
2+/TPrA ECL readout. 
 
Figure 15. Fundamental principle of the multichannel closed bipolar electrode ECL sensor for analyte detection.  
Note that the figure is not to scale and the BPEs are indeed gold nanowires with 210 nm. radius. Reprinted from 
Ref.[124]with permission of the American Chemical Society. 
 
The multichannel PET membrane, after exposure to ion-beam and UV sensitization, can be 
etched to the desired pore diameter by NaOH. Using ECL at the CBPEC array several 
analytes were detected such as dopamine, H2O2, AFP, and carcino- CEA. The practical 
applicability was tested by analyzing AFP and CEA in human serum, confirming the 
potentiality of the device for multi-analysis purposes.  
A novel ECL immunosensor for celiac disease diagnosis, based on NEEs was recently 
proposed [125]. The sensing strategy was based on the spatial segregation between the sites 
where the initial electrochemical reaction and ECL emission occur. As shown in Figure 16, 
tissue transglutaminase (tTG) was used as capture agent. It was immobilized on the 
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polycarbonate (PC) surface of the track-etched membrane used as template to fabricate the 
NEE, and exploited to bind the target tissue transglutaminase antibody (anti-tTG). This was 
reacted with a sec-Ab labeled with a ruthenium luminophore.  Other details of the detection 
strategy are illustrated in the caption of Figure 16. 
 
 
 
Figure 16.  a) Scheme showing the design of the immunosensor (not in scale). The PC surface is first modified 
with the capture protein, tTG. The assay is performed by incubating it with a sample containing the target (i.e. 
anti-tTG antibody) and then in a solution of a biotinylated secondary antibody. The final step consists in 
attaching the ECL label by exposing the immunosensor to a solution containing a streptavidin-modified 
Ru(bpy)3
2+ complex (SA-Ru). Oxidation of TPrA occurs at each Au nanoelectrode of the NEEs and the 
resulting radicals, TPrA●+ and TPrA●, diffuse over short distances and react with the luminophore label attached 
to the PC to generate the ECL emission. Note that the figure is not to scale and the Au nanoelectrodes  have a 
nominal diameter of 30 nm. b) Field emission scanning electron microscopy (FE-SEM) images of a gold-NEE at 
two magnifications. Reprinted from Ref.[125] with permission of the American Chemical Society. 
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It is worth stressing that the electroactive surface is composed by an ensemble of gold 
nanodisk electrodes with radius of 15-25 nm (see Fig. 16 b) and the biorecognition 
component (including the ECL label) is immobilized on the polycarbonate template in which 
the nanoelectrodes are embedded..Voltammetric and ECL analyses demonstrated that, in this 
sensor, the ruthenium complex is not oxidized directly at the surface of the nanoelectrodes, 
but ECL is generated solely via TPrA oxidation at 0.88 V vs. Ag/AgCl to produce TPrA●+ 
and TPrA● radicals, according to the scheme [82], [120]:    
TPrA●+    TPrA● + H+       (35) 
TPrA● + PC—…—Ru(bpy)3
2+    Im+ + PC—…—Ru(bpy)3
+  (36) 
TPrA●+ + PC—…—Ru(bpy)3
+    TPrA + PC—…—Ru(bpy)3
2+∗  (37) 
PC—…—Ru(bpy)3
2+∗    PC—…—Ru(bpy)3
2+ + hνECL   (38) 
where Im+ is the iminium product and PC—…—Ru(bpy)3
2+ represents the ruthenium label 
attached to the PC surface via the biorecognition chain described in Figure 16.   
Analysis performed in human serum samples, demonstrated that the NEE-based ECL 
immunosensor is able to discriminate between healthy individuals and celiac patients. 
Insight into the parameters which influence the generation of ECL at arrays of 
nanoelectrodes, was recently obtained by preparing and studying NEAs with highly-
controlled geometry [126]. The substrate electrode material used to this aim was boron-doped 
diamond (BDD). BDD is particularly attractive for ECL studies thanks to its high chemical 
and electrochemical stability, satisfactory electrical conductivity and wide potential 
window[126], [127] The preparation of arrays and ensembles of BDD nanoelectrodes have been 
previously achieved by nanoparticles templated procedure [123], by nanosphere lithography 
[124] and by e-beam lithography[128]. 
In this work, NEAs with 16 different geometries were fabricated on the same BDD substrate 
by using a highly controllable e-beam lithographic procedure [129] . A multiple nanoelectrode 
arrays platform (MNEAP) was prepared, being composed by arrays of individual electrodes 
with critical size from 100 to 1000 nm (see Figure 17).  
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Figure 17. (a) Schematic drawing of the fabricated MNEAP. The parameters r, d, w and D correspond to the 
disc radius, the centre-to-centre distance between discs, the width of the bands and the pitch between the 
bands, respectively. The identification key of the NEAs in the platform is displayed in ESM Fig. S1. (b) 
Scanning electron micrographs of a BDD-based NEA constituted by nanodisc electrodes with r = 150 ± 10 nm 
and d = 3 μm at different magnifications. Reprinted from Ref.[130] with permission of Springer. 
 
By microscopic ECL imaging by a CCD camera, it was possible to capture simultaneously, in 
a single image, the ECL emitted from the different NEAs, allowing to study the intensity and 
spatial distribution of the ECL emission as a function of the geometrical features of the array 
as well as of the concentration of the TPrA coreactant (see Figure 18). The analysis of the 
ECL imaging data indicated that the ECL emitting zone scales inversely with the coreactant 
concentration as well as significantly more intense ECL signals were detected for NEAs 
operating under overlap conditions. Note that individual ECL emission at nanoelectrodes 
with critical dimension as small as 300 nm were imaged.  
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Figure 18. ECL images of a BDD-NEA obtained in phosphate buffer (pH 7.4) containing 1 mM Ru(bpy)32+ and 
increasing concentrations of TPrA (indicated in top-left corner of each box). Images were recorded in the dark 
with a ×50 objective when applying a constant potential of 1.2 V vs. Ag/AgCl/KCl. All images were coded 
according to the same false colour scale (right). Reprinted from Ref.[130] with permission of Springer.. 
 
Conclusions 
Analytical applications based on ECL have dramatically increased over the last five years and 
the impact they are having especially in bioanalyses and medical diagnostics is tremendous. 
Simplicity in instrumentation and high sensitivity make ECL a very appealing analytical 
technique characterised by fast response times, ease of use, and unprecedented sensitivity up 
to the atto molar level. All these achievements have been possible thanks to the synthesis of 
highly luminescent nanomaterials such as quantum dots, as well as by the improved detection 
capabilities offered  by arrays of nanoelectrodes with very low background current, along 
with various strategies for bioconjugation of biomolecules on nanomaterials. Therefore, ECL 
is set to play a key role in the field  of analytical sensors and bioanalysis, and recent 
applications can lead, in the near future, to develop novel portable and highly miniaturized 
and sensitive devices suitable for many applications, e.g. for biomedical use or the 
decentralized monitoring of chemical and biochemical hazards. These applications rely on 
highly selective and sensitive instrumentations, coupled with friendly use and affordable cost, 
all in miniaturized sensing devices, thank to the use of nanomaterials and nanoelectrodes 
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which warranty high ECL signals from sensors with very small geometric area. In this 
respect, ECL with nanodots and nanoelectrodes fulfils all these criteria and it is highly likely 
that future developments, especially in medical diagnostics, will grow dramatically. 
From an experimental viewpoint, future research efforts should be directed in the direction of 
improving the spatial resolution and sensitivity necessary to face with the measurement and 
imaging challenges of ECL detection from nanometre sized objects. The recent experimental 
studies presented in this review indicate the lines of development to be followed. However 
they outline the requirement of being supported by theoretical studies capable to model ECL 
emission from arrays of nanometric ECL emitters operating under different experimental 
conditions, e.g. overlapping or non-overlapping configurations.  
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